

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.94061524 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.94061524 |
| 3 | aromatic amino acid family catabolic process (GO:0009074) | 6.52291217 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.48551396 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.48551396 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.16591490 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.16591490 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.16591490 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.11775166 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.97063446 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.88828081 |
| 12 | urea metabolic process (GO:0019627) | 5.74334679 |
| 13 | urea cycle (GO:0000050) | 5.74334679 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.64231799 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.43484108 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.33042555 |
| 17 | nitrogen cycle metabolic process (GO:0071941) | 5.21275509 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.18001024 |
| 19 | protein carboxylation (GO:0018214) | 5.18001024 |
| 20 | regulation of protein activation cascade (GO:2000257) | 5.17367793 |
| 21 | cysteine metabolic process (GO:0006534) | 5.16188716 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.13808262 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.11211944 |
| 24 | glyoxylate metabolic process (GO:0046487) | 5.01012312 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.97689982 |
| 26 | bile acid metabolic process (GO:0008206) | 4.88881816 |
| 27 | reverse cholesterol transport (GO:0043691) | 4.87552468 |
| 28 | regulation of complement activation (GO:0030449) | 4.83016974 |
| 29 | bile acid and bile salt transport (GO:0015721) | 4.81349787 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.80570185 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.78643628 |
| 32 | phospholipid efflux (GO:0033700) | 4.76047339 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.74935671 |
| 34 | tyrosine metabolic process (GO:0006570) | 4.72864990 |
| 35 | negative regulation of cell killing (GO:0031342) | 4.70753668 |
| 36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.70753668 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.68117142 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.65165450 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.64687864 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.64687864 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.64687864 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.60495425 |
| 43 | indolalkylamine metabolic process (GO:0006586) | 4.49163071 |
| 44 | negative regulation of sterol transport (GO:0032372) | 4.45660208 |
| 45 | negative regulation of cholesterol transport (GO:0032375) | 4.45660208 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.44202063 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.41051673 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 4.40614793 |
| 49 | cholesterol efflux (GO:0033344) | 4.40421384 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.38544932 |
| 51 | cellular glucuronidation (GO:0052695) | 4.35718101 |
| 52 | cellular biogenic amine catabolic process (GO:0042402) | 4.35695579 |
| 53 | amine catabolic process (GO:0009310) | 4.35695579 |
| 54 | plasma lipoprotein particle assembly (GO:0034377) | 4.34603491 |
| 55 | lysine metabolic process (GO:0006553) | 4.34375651 |
| 56 | lysine catabolic process (GO:0006554) | 4.34375651 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.33096315 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.33096315 |
| 59 | drug catabolic process (GO:0042737) | 4.32765080 |
| 60 | ethanol oxidation (GO:0006069) | 4.30788606 |
| 61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.25755330 |
| 62 | alpha-amino acid catabolic process (GO:1901606) | 4.23768288 |
| 63 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.16881258 |
| 64 | phospholipid homeostasis (GO:0055091) | 4.13859337 |
| 65 | glutamate metabolic process (GO:0006536) | 4.13120980 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 4.08615952 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 4.08004563 |
| 68 | regulation of bile acid biosynthetic process (GO:0070857) | 4.04466112 |
| 69 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.97860901 |
| 70 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93887337 |
| 71 | protein-lipid complex assembly (GO:0065005) | 3.91406775 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 3.90719824 |
| 73 | imidazole-containing compound metabolic process (GO:0052803) | 3.89033851 |
| 74 | fibrinolysis (GO:0042730) | 3.88974576 |
| 75 | response to nitrosative stress (GO:0051409) | 3.88508031 |
| 76 | arginine metabolic process (GO:0006525) | 3.86887744 |
| 77 | coenzyme catabolic process (GO:0009109) | 3.85734835 |
| 78 | uronic acid metabolic process (GO:0006063) | 3.85086660 |
| 79 | glucuronate metabolic process (GO:0019585) | 3.85086660 |
| 80 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.84665196 |
| 81 | hemoglobin metabolic process (GO:0020027) | 3.83372634 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 3.83356477 |
| 83 | exogenous drug catabolic process (GO:0042738) | 3.82391026 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.81328636 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.78710550 |
| 86 | plasma lipoprotein particle organization (GO:0071827) | 3.78186339 |
| 87 | complement activation, classical pathway (GO:0006958) | 3.78079263 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 3.74343675 |
| 89 | flavonoid metabolic process (GO:0009812) | 3.73362925 |
| 90 | response to interleukin-15 (GO:0070672) | 3.70959487 |
| 91 | detection of molecule of bacterial origin (GO:0032490) | 3.70853844 |
| 92 | complement activation (GO:0006956) | 3.68118222 |
| 93 | protein activation cascade (GO:0072376) | 3.66693791 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.66305641 |
| 95 | cellular modified amino acid catabolic process (GO:0042219) | 3.65632966 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.64922211 |
| 97 | positive regulation by symbiont of host defense response (GO:0052509) | 3.62309105 |
| 98 | modulation by symbiont of host defense response (GO:0052031) | 3.62309105 |
| 99 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.62309105 |
| 100 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.62309105 |
| 101 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.62309105 |
| 102 | modulation by symbiont of host immune response (GO:0052553) | 3.62309105 |
| 103 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.60931876 |
| 104 | sterol homeostasis (GO:0055092) | 3.60544106 |
| 105 | cofactor catabolic process (GO:0051187) | 3.59366343 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 3.57900399 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.57585500 |
| 108 | protein-lipid complex subunit organization (GO:0071825) | 3.56744191 |
| 109 | epoxygenase P450 pathway (GO:0019373) | 3.53848211 |
| 110 | negative regulation of protein activation cascade (GO:2000258) | 3.52367741 |
| 111 | serine family amino acid metabolic process (GO:0009069) | 3.52039521 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.50516480 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.50516480 |
| 114 | glycine metabolic process (GO:0006544) | 3.46526584 |
| 115 | drug metabolic process (GO:0017144) | 3.46326565 |
| 116 | lipoprotein metabolic process (GO:0042157) | 3.46048410 |
| 117 | detection of other organism (GO:0098543) | 3.44431730 |
| 118 | cytolysis (GO:0019835) | 3.41855454 |
| 119 | oxygen transport (GO:0015671) | 3.39362878 |
| 120 | detection of external biotic stimulus (GO:0098581) | 3.37893667 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 3.31022542 |
| 122 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.29295251 |
| 123 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.27597920 |
| 124 | detection of bacterium (GO:0016045) | 3.21210298 |
| 125 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.19113638 |
| 126 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.14505550 |
| 127 | macrophage activation involved in immune response (GO:0002281) | 3.13235223 |
| 128 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.09021852 |
| 129 | negative thymic T cell selection (GO:0045060) | 3.08976016 |
| 130 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.07804741 |
| 131 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.07349939 |
| 132 | negative T cell selection (GO:0043383) | 3.04675187 |
| 133 | cellular extravasation (GO:0045123) | 3.04665815 |
| 134 | erythrocyte development (GO:0048821) | 3.04148013 |
| 135 | cellular response to interleukin-15 (GO:0071350) | 3.01317923 |
| 136 | positive regulation of hemostasis (GO:1900048) | 3.00832380 |
| 137 | positive regulation of blood coagulation (GO:0030194) | 3.00832380 |
| 138 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00748285 |
| 139 | histone H3-K36 demethylation (GO:0070544) | 2.97817880 |
| 140 | positive thymic T cell selection (GO:0045059) | 2.93246953 |
| 141 | regulation of humoral immune response (GO:0002920) | 2.88952922 |
| 142 | positive regulation of granulocyte differentiation (GO:0030854) | 2.88156591 |
| 143 | gas transport (GO:0015669) | 2.87748109 |
| 144 | positive regulation of coagulation (GO:0050820) | 2.84760604 |
| 145 | positive T cell selection (GO:0043368) | 2.83862054 |
| 146 | detection of biotic stimulus (GO:0009595) | 2.83821750 |
| 147 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.81657797 |
| 148 | erythrocyte maturation (GO:0043249) | 2.81481184 |
| 149 | regulation of T cell tolerance induction (GO:0002664) | 2.81125323 |
| 150 | type I interferon signaling pathway (GO:0060337) | 2.81059510 |
| 151 | cellular response to type I interferon (GO:0071357) | 2.81059510 |
| 152 | response to type I interferon (GO:0034340) | 2.78582463 |
| 153 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.76384312 |
| 154 | positive regulation of humoral immune response (GO:0002922) | 2.68338408 |
| 155 | positive regulation of B cell differentiation (GO:0045579) | 2.67064503 |
| 156 | response to mercury ion (GO:0046689) | 2.66136833 |
| 157 | negative regulation of T cell mediated immunity (GO:0002710) | 2.65918782 |
| 158 | hepatocyte apoptotic process (GO:0097284) | 2.64236855 |
| 159 | neutrophil activation involved in immune response (GO:0002283) | 2.63603379 |
| 160 | leukocyte aggregation (GO:0070486) | 2.60895753 |
| 161 | regulation of tolerance induction (GO:0002643) | 2.59926436 |
| 162 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.56101863 |
| 163 | response to methylmercury (GO:0051597) | 2.55389905 |
| 164 | myeloid cell development (GO:0061515) | 2.54528646 |
| 165 | positive regulation of Rap GTPase activity (GO:0032854) | 2.54493946 |
| 166 | negative regulation of interleukin-12 production (GO:0032695) | 2.54070836 |
| 167 | microglial cell activation (GO:0001774) | 2.53583810 |
| 168 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.50469302 |
| 169 | omega-hydroxylase P450 pathway (GO:0097267) | 2.49924258 |
| 170 | T cell selection (GO:0045058) | 2.49386888 |
| 171 | negative regulation of type 2 immune response (GO:0002829) | 2.49053496 |
| 172 | positive regulation of extracellular matrix organization (GO:1903055) | 2.48458012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.27115450 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.27193628 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.15909777 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.83174538 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.53008034 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.26838518 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.15974295 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.86245030 |
| 9 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.62303162 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.22976959 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.19899180 |
| 12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.83124236 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.81455624 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59735582 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.53551704 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.46650228 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.37989614 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.16611837 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.03053740 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02825805 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.01532904 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2133424 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.98824298 |
| 24 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93175207 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.93067314 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93058219 |
| 27 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89039580 |
| 28 | * MAF_26560356_Chip-Seq_TH1_Human | 1.88221302 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.86633555 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80615166 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79688802 |
| 32 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.77994121 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72475560 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70019598 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67496713 |
| 36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66034467 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65827710 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64701120 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59784819 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59024312 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.57949387 |
| 42 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53967657 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53462072 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52075223 |
| 45 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51560913 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49097039 |
| 47 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48489700 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48259132 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.46202172 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45204259 |
| 51 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.41707250 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41420698 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.40730765 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38982714 |
| 55 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36894220 |
| 56 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34761262 |
| 57 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32295695 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25545990 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24383920 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23942540 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19473978 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17676977 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16195368 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15062302 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13292115 |
| 66 | * MAF_26560356_Chip-Seq_TH2_Human | 1.12994304 |
| 67 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.12062280 |
| 68 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11787964 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08627575 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07782938 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07218890 |
| 72 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07195810 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05272714 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03667078 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02844741 |
| 76 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99560701 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98705872 |
| 78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98072753 |
| 79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97490382 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97150825 |
| 81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97150825 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96691848 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96297533 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95813867 |
| 85 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95678911 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95504353 |
| 87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94693727 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93610175 |
| 89 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92455660 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91502924 |
| 91 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91249353 |
| 92 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90979831 |
| 93 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87158709 |
| 94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86845283 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86199486 |
| 96 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.86150517 |
| 97 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85957267 |
| 98 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85936178 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85287489 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84986688 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84968858 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84212584 |
| 103 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.84188735 |
| 104 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83931033 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83882709 |
| 106 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.83473244 |
| 107 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82785272 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81937532 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81541603 |
| 110 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80966164 |
| 111 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80621538 |
| 112 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.79778316 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78317659 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78235761 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.77658996 |
| 116 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77657021 |
| 117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77152593 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.73162973 |
| 119 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.72464562 |
| 120 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.70502664 |
| 121 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69435533 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.68615491 |
| 123 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67576728 |
| 124 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.65664468 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.65026440 |
| 126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.64816146 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.64218325 |
| 128 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.63174057 |
| 129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63169196 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62186241 |
| 131 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.61215607 |
| 132 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.60591908 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.58741504 |
| 134 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.58441400 |
| 135 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.58309705 |
| 136 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.57404264 |
| 137 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.56910975 |
| 138 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.56708419 |
| 139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56536187 |
| 140 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55902482 |
| 141 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.55841704 |
| 142 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.53875208 |
| 143 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.53830879 |
| 144 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.53486569 |
| 145 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.53403300 |
| 146 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.51858757 |
| 147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51286257 |
| 148 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.51268238 |
| 149 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.50902230 |
| 150 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.50671385 |
| 151 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.50463642 |
| 152 | RXR_22108803_ChIP-Seq_LS180_Human | 0.50273240 |
| 153 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.49204598 |
| 154 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.48778760 |
| 155 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.47765082 |
| 156 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.47432763 |
| 157 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.47288277 |
| 158 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.47042320 |
| 159 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.47030323 |
| 160 | TP53_16413492_ChIP-PET_HCT116_Human | 0.46787801 |
| 161 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.46680328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.23360491 |
| 2 | MP0005360_urolithiasis | 7.47262952 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.35636190 |
| 4 | MP0005365_abnormal_bile_salt | 5.95189695 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.40973458 |
| 6 | MP0003252_abnormal_bile_duct | 4.18307839 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.62695338 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.01932471 |
| 9 | MP0005083_abnormal_biliary_tract | 2.97106160 |
| 10 | MP0003303_peritoneal_inflammation | 2.83853081 |
| 11 | MP0009840_abnormal_foam_cell | 2.72923537 |
| 12 | MP0008260_abnormal_autophagy | 2.67329038 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.51838682 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.51774336 |
| 15 | MP0005332_abnormal_amino_acid | 2.49971679 |
| 16 | MP0003195_calcinosis | 2.30505468 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.29989293 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.29499678 |
| 19 | MP0001835_abnormal_antigen_presentation | 2.28609122 |
| 20 | MP0000685_abnormal_immune_system | 2.28365795 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.19757300 |
| 22 | MP0000609_abnormal_liver_physiology | 2.13970594 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.11445879 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 2.03919967 |
| 25 | MP0009697_abnormal_copulation | 2.02084552 |
| 26 | MP0005025_abnormal_response_to | 2.01171693 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.00964214 |
| 28 | MP0001800_abnormal_humoral_immune | 1.95685642 |
| 29 | MP0003868_abnormal_feces_composition | 1.83140166 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.81205792 |
| 31 | MP0005387_immune_system_phenotype | 1.79070700 |
| 32 | MP0001790_abnormal_immune_system | 1.79070700 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.74601314 |
| 34 | MP0002723_abnormal_immune_serum | 1.70939173 |
| 35 | MP0005671_abnormal_response_to | 1.70653910 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.63697401 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.63697401 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.63044161 |
| 39 | MP0001819_abnormal_immune_cell | 1.60318923 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.59939000 |
| 41 | MP0002398_abnormal_bone_marrow | 1.57419211 |
| 42 | MP0002405_respiratory_system_inflammati | 1.54279223 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.53132440 |
| 44 | MP0001764_abnormal_homeostasis | 1.42666850 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41933584 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.39552694 |
| 47 | MP0004947_skin_inflammation | 1.39031405 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.38760043 |
| 49 | MP0009764_decreased_sensitivity_to | 1.37995391 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.37284272 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.36952491 |
| 52 | MP0002722_abnormal_immune_system | 1.35906412 |
| 53 | MP0000716_abnormal_immune_system | 1.35496085 |
| 54 | MP0003866_abnormal_defecation | 1.34750509 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.33858664 |
| 56 | MP0003011_delayed_dark_adaptation | 1.31595649 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.27613261 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.23263466 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.22319726 |
| 60 | MP0003828_pulmonary_edema | 1.22088349 |
| 61 | MP0000858_altered_metastatic_potential | 1.20946493 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.20665630 |
| 63 | MP0005310_abnormal_salivary_gland | 1.20062568 |
| 64 | MP0001851_eye_inflammation | 1.19102123 |
| 65 | MP0002254_reproductive_system_inflammat | 1.17803297 |
| 66 | MP0000598_abnormal_liver_morphology | 1.17599915 |
| 67 | MP0002429_abnormal_blood_cell | 1.15959408 |
| 68 | MP0002148_abnormal_hypersensitivity_rea | 1.09685393 |
| 69 | MP0001915_intracranial_hemorrhage | 1.07490813 |
| 70 | MP0003045_fibrosis | 1.06186679 |
| 71 | MP0005647_abnormal_sex_gland | 1.05818195 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.05745923 |
| 73 | MP0005451_abnormal_body_composition | 1.05364948 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 1.05042084 |
| 75 | MP0005076_abnormal_cell_differentiation | 1.04580365 |
| 76 | MP0000604_amyloidosis | 1.03852479 |
| 77 | MP0009763_increased_sensitivity_to | 1.03185898 |
| 78 | MP0003186_abnormal_redox_activity | 1.02970617 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 1.00818776 |
| 80 | MP0008469_abnormal_protein_level | 0.98067484 |
| 81 | MP0004147_increased_porphyrin_level | 0.96226339 |
| 82 | MP0005670_abnormal_white_adipose | 0.95235634 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.93231249 |
| 84 | MP0005464_abnormal_platelet_physiology | 0.93146548 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.89049281 |
| 86 | MP0003566_abnormal_cell_adhesion | 0.87939374 |
| 87 | MP0009278_abnormal_bone_marrow | 0.86821881 |
| 88 | MP0009642_abnormal_blood_homeostasis | 0.86702721 |
| 89 | MP0009053_abnormal_anal_canal | 0.86513371 |
| 90 | MP0005408_hypopigmentation | 0.84505600 |
| 91 | MP0003091_abnormal_cell_migration | 0.83523509 |
| 92 | MP0002006_tumorigenesis | 0.80415955 |
| 93 | MP0008004_abnormal_stomach_pH | 0.78503149 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.78135823 |
| 95 | MP0003690_abnormal_glial_cell | 0.77693311 |
| 96 | MP0002928_abnormal_bile_duct | 0.74231104 |
| 97 | MP0001756_abnormal_urination | 0.73525107 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.72355891 |
| 99 | MP0005334_abnormal_fat_pad | 0.70400802 |
| 100 | MP0000920_abnormal_myelination | 0.69847302 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.69271554 |
| 102 | MP0005409_darkened_coat_color | 0.68661388 |
| 103 | MP0005084_abnormal_gallbladder_morpholo | 0.67590271 |
| 104 | MP0004510_myositis | 0.67587778 |
| 105 | MP0003724_increased_susceptibility_to | 0.66986224 |
| 106 | MP0008872_abnormal_physiological_respon | 0.66465429 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.66218294 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.65964131 |
| 109 | MP0005166_decreased_susceptibility_to | 0.65671892 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.65637718 |
| 111 | MP0002078_abnormal_glucose_homeostasis | 0.64500618 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.64190570 |
| 113 | MP0005058_abnormal_lysosome_morphology | 0.63982193 |
| 114 | MP0002971_abnormal_brown_adipose | 0.63359870 |
| 115 | MP0003300_gastrointestinal_ulcer | 0.60558561 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.59560888 |
| 117 | MP0002132_abnormal_respiratory_system | 0.58447575 |
| 118 | MP0003436_decreased_susceptibility_to | 0.56108168 |
| 119 | MP0005535_abnormal_body_temperature | 0.54784033 |
| 120 | MP0003075_altered_response_to | 0.54763413 |
| 121 | MP0004264_abnormal_extraembryonic_tissu | 0.54399864 |
| 122 | MP0002168_other_aberrant_phenotype | 0.52923147 |
| 123 | MP0008873_increased_physiological_sensi | 0.50605638 |
| 124 | MP0005220_abnormal_exocrine_pancreas | 0.50050791 |
| 125 | MP0005248_abnormal_Harderian_gland | 0.49462680 |
| 126 | MP0005395_other_phenotype | 0.48531114 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.47141531 |
| 128 | MP0002135_abnormal_kidney_morphology | 0.46277980 |
| 129 | MP0008874_decreased_physiological_sensi | 0.45689145 |
| 130 | MP0002090_abnormal_vision | 0.44810122 |
| 131 | MP0005448_abnormal_energy_balance | 0.44589079 |
| 132 | MP0004130_abnormal_muscle_cell | 0.43087198 |
| 133 | MP0001177_atelectasis | 0.42828379 |
| 134 | MP0006082_CNS_inflammation | 0.42288751 |
| 135 | MP0001853_heart_inflammation | 0.42250843 |
| 136 | MP0002822_catalepsy | 0.41767905 |
| 137 | MP0000249_abnormal_blood_vessel | 0.41083877 |
| 138 | MP0001845_abnormal_inflammatory_respons | 0.40781915 |
| 139 | MP0002419_abnormal_innate_immunity | 0.40253976 |
| 140 | MP0004883_abnormal_blood_vessel | 0.38675308 |
| 141 | MP0010234_abnormal_vibrissa_follicle | 0.37683192 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.36925165 |
| 143 | MP0003329_amyloid_beta_deposits | 0.36501265 |
| 144 | MP0005266_abnormal_metabolism | 0.36202134 |
| 145 | MP0003953_abnormal_hormone_level | 0.35236541 |
| 146 | MP0005164_abnormal_response_to | 0.33329038 |
| 147 | MP0005646_abnormal_pituitary_gland | 0.32973333 |
| 148 | MP0009115_abnormal_fat_cell | 0.32443370 |
| 149 | MP0002295_abnormal_pulmonary_circulatio | 0.30444106 |
| 150 | MP0001324_abnormal_eye_pigmentation | 0.29667289 |
| 151 | MP0001661_extended_life_span | 0.29621413 |
| 152 | MP0006036_abnormal_mitochondrial_physio | 0.29288178 |
| 153 | MP0009785_altered_susceptibility_to | 0.28573781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.22721633 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.85163784 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.40501647 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.33738854 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.06647652 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.05673014 |
| 7 | Xanthomatosis (HP:0000991) | 5.94437447 |
| 8 | Complement deficiency (HP:0004431) | 5.48737054 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.38447295 |
| 10 | Joint hemorrhage (HP:0005261) | 4.77178941 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.58859399 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 4.52713956 |
| 13 | Epidermoid cyst (HP:0200040) | 4.42025010 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.29829107 |
| 15 | Eczematoid dermatitis (HP:0000976) | 4.27592706 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.26088436 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.24087297 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.08351604 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.05895011 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 3.94889953 |
| 21 | Hyperammonemia (HP:0001987) | 3.94351675 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.90665743 |
| 23 | Abnormality of complement system (HP:0005339) | 3.90622031 |
| 24 | Fat malabsorption (HP:0002630) | 3.89461214 |
| 25 | Hypochromic anemia (HP:0001931) | 3.78843532 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.73367475 |
| 27 | Hypercholesterolemia (HP:0003124) | 3.69816421 |
| 28 | Hyperbilirubinemia (HP:0002904) | 3.67119932 |
| 29 | Hypochromic microcytic anemia (HP:0004840) | 3.67109619 |
| 30 | Acanthocytosis (HP:0001927) | 3.65697048 |
| 31 | Ketosis (HP:0001946) | 3.59268919 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59170262 |
| 33 | Myositis (HP:0100614) | 3.46488087 |
| 34 | Orchitis (HP:0100796) | 3.38821625 |
| 35 | Poikilocytosis (HP:0004447) | 3.38527926 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.37027177 |
| 37 | Hyperglycinemia (HP:0002154) | 3.30023811 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 3.28026961 |
| 39 | Recurrent abscess formation (HP:0002722) | 3.24781871 |
| 40 | Optic neuritis (HP:0100653) | 3.24726469 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 3.24726469 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.20833602 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 3.17403439 |
| 44 | Vascular calcification (HP:0004934) | 3.11102181 |
| 45 | * Microcytic anemia (HP:0001935) | 3.10645831 |
| 46 | Abnormality of macrophages (HP:0004311) | 3.07650087 |
| 47 | Myocardial infarction (HP:0001658) | 3.05849326 |
| 48 | Hyperglycinuria (HP:0003108) | 3.04111883 |
| 49 | Spontaneous abortion (HP:0005268) | 3.03346859 |
| 50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.02367990 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01841376 |
| 52 | Hypoglycemic coma (HP:0001325) | 2.97755257 |
| 53 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.96861535 |
| 54 | Abnormality of glycine metabolism (HP:0010895) | 2.96861535 |
| 55 | Glomerulonephritis (HP:0000099) | 2.92896135 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.92886251 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.89400296 |
| 58 | Steatorrhea (HP:0002570) | 2.79846922 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.79755876 |
| 60 | T lymphocytopenia (HP:0005403) | 2.79094417 |
| 61 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.76902286 |
| 62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.76236398 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 2.73176934 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.72402022 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.70716032 |
| 66 | Cholelithiasis (HP:0001081) | 2.70354264 |
| 67 | Recurrent fungal infections (HP:0002841) | 2.69617481 |
| 68 | Delayed CNS myelination (HP:0002188) | 2.69320326 |
| 69 | Metabolic acidosis (HP:0001942) | 2.68437697 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.66828499 |
| 71 | Gingivitis (HP:0000230) | 2.65604131 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.64257824 |
| 73 | Recurrent skin infections (HP:0001581) | 2.63698067 |
| 74 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.59828672 |
| 75 | Pulmonary embolism (HP:0002204) | 2.59086610 |
| 76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56379486 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56379486 |
| 78 | Esophageal varix (HP:0002040) | 2.54951961 |
| 79 | Slow saccadic eye movements (HP:0000514) | 2.54816600 |
| 80 | Gingival bleeding (HP:0000225) | 2.53917595 |
| 81 | Amyloidosis (HP:0011034) | 2.48408115 |
| 82 | Skin nodule (HP:0200036) | 2.48316640 |
| 83 | Abnormality of the fingertips (HP:0001211) | 2.47992030 |
| 84 | Meningitis (HP:0001287) | 2.45765218 |
| 85 | Cholecystitis (HP:0001082) | 2.45465458 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.45465458 |
| 87 | Alkalosis (HP:0001948) | 2.44964838 |
| 88 | Encephalitis (HP:0002383) | 2.40806755 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 2.39916657 |
| 90 | Abnormality of serum amino acid levels (HP:0003112) | 2.38681486 |
| 91 | Peritonitis (HP:0002586) | 2.38657405 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.38420469 |
| 93 | Stomatitis (HP:0010280) | 2.35355727 |
| 94 | Osteomalacia (HP:0002749) | 2.35274065 |
| 95 | Mitral stenosis (HP:0001718) | 2.34962670 |
| 96 | Purpura (HP:0000979) | 2.34807471 |
| 97 | Gout (HP:0001997) | 2.33937683 |
| 98 | Enlarged kidneys (HP:0000105) | 2.32421212 |
| 99 | Ketoacidosis (HP:0001993) | 2.29771748 |
| 100 | Menorrhagia (HP:0000132) | 2.28070413 |
| 101 | * Vasculitis (HP:0002633) | 2.27576970 |
| 102 | Malnutrition (HP:0004395) | 2.26976674 |
| 103 | Reticulocytosis (HP:0001923) | 2.23760700 |
| 104 | Arterial thrombosis (HP:0004420) | 2.22643569 |
| 105 | Nephritis (HP:0000123) | 2.21732455 |
| 106 | Thrombophlebitis (HP:0004418) | 2.18791539 |
| 107 | Recurrent viral infections (HP:0004429) | 2.18786804 |
| 108 | Cellulitis (HP:0100658) | 2.18706013 |
| 109 | Hypoglycemic seizures (HP:0002173) | 2.17619228 |
| 110 | Abnormal hemoglobin (HP:0011902) | 2.13765918 |
| 111 | Upper motor neuron abnormality (HP:0002127) | 2.13322646 |
| 112 | Joint swelling (HP:0001386) | 2.12818375 |
| 113 | Status epilepticus (HP:0002133) | 2.12262937 |
| 114 | Abnormality of the gallbladder (HP:0005264) | 2.11255231 |
| 115 | Abnormal platelet volume (HP:0011876) | 2.10388530 |
| 116 | Spastic diplegia (HP:0001264) | 2.07687681 |
| 117 | Keratoconjunctivitis (HP:0001096) | 2.07111173 |
| 118 | Hemorrhage of the eye (HP:0011885) | 2.06253086 |
| 119 | Anorexia (HP:0002039) | 2.02668429 |
| 120 | Autoimmune hemolytic anemia (HP:0001890) | 2.02073916 |
| 121 | Neonatal onset (HP:0003623) | 2.01094123 |
| 122 | Inflammation of the large intestine (HP:0002037) | 2.01020786 |
| 123 | Hydroxyprolinuria (HP:0003080) | 2.00839527 |
| 124 | Abnormality of proline metabolism (HP:0010907) | 2.00839527 |
| 125 | Obstructive lung disease (HP:0006536) | 2.00290208 |
| 126 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00290208 |
| 127 | Polycythemia (HP:0001901) | 1.97784118 |
| 128 | Mediastinal lymphadenopathy (HP:0100721) | 1.97299679 |
| 129 | Renal cortical cysts (HP:0000803) | 1.97210014 |
| 130 | Subacute progressive viral hepatitis (HP:0006572) | 1.97013302 |
| 131 | Abnormality of T cells (HP:0002843) | 1.94075616 |
| 132 | Gastrointestinal inflammation (HP:0004386) | 1.93544895 |
| 133 | Opisthotonus (HP:0002179) | 1.92975063 |
| 134 | Irritability (HP:0000737) | 1.92849298 |
| 135 | Increased serum ferritin (HP:0003281) | 1.92301198 |
| 136 | Pancreatitis (HP:0001733) | 1.90664071 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90286588 |
| 138 | Toxemia of pregnancy (HP:0100603) | 1.87980095 |
| 139 | Increased IgE level (HP:0003212) | 1.87787098 |
| 140 | Episodic fever (HP:0001954) | 1.86569365 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 1.86434064 |
| 142 | Lethargy (HP:0001254) | 1.83674887 |
| 143 | Fair hair (HP:0002286) | 1.83442439 |
| 144 | Rickets (HP:0002748) | 1.82960146 |
| 145 | Neonatal hypoglycemia (HP:0001998) | 1.82272617 |
| 146 | Gangrene (HP:0100758) | 1.80738360 |
| 147 | Vomiting (HP:0002013) | 1.80137382 |
| 148 | Urticaria (HP:0001025) | 1.79996748 |
| 149 | Hemoptysis (HP:0002105) | 1.79328579 |
| 150 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.76442863 |
| 151 | Abnormal platelet function (HP:0011869) | 1.76381079 |
| 152 | Impaired platelet aggregation (HP:0003540) | 1.76381079 |
| 153 | Brushfield spots (HP:0001088) | 1.75633327 |
| 154 | Epistaxis (HP:0000421) | 1.75253608 |
| 155 | Increased mean platelet volume (HP:0011877) | 1.74340288 |
| 156 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74244670 |
| 157 | Dicarboxylic aciduria (HP:0003215) | 1.74244670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.88895636 |
| 2 | PRPF4B | 3.83222121 |
| 3 | BCKDK | 3.50287684 |
| 4 | ERN1 | 3.32932259 |
| 5 | MST1R | 3.28269691 |
| 6 | SIK1 | 3.26237191 |
| 7 | RIPK4 | 2.96497384 |
| 8 | FGFR4 | 2.85956346 |
| 9 | MAP4K1 | 2.62626643 |
| 10 | INSRR | 2.49865244 |
| 11 | LATS1 | 2.36117019 |
| 12 | MAP2K4 | 2.16362105 |
| 13 | ERBB4 | 2.04566679 |
| 14 | TYK2 | 1.96283425 |
| 15 | MAP3K14 | 1.91656543 |
| 16 | IRAK4 | 1.77152692 |
| 17 | NEK9 | 1.76936742 |
| 18 | ZAP70 | 1.75990022 |
| 19 | PIK3CA | 1.75784262 |
| 20 | SGK3 | 1.72422127 |
| 21 | TGFBR2 | 1.71035002 |
| 22 | SGK2 | 1.69585628 |
| 23 | WNK1 | 1.69269549 |
| 24 | FES | 1.65220163 |
| 25 | JAK3 | 1.61818525 |
| 26 | MAP3K2 | 1.60984268 |
| 27 | EPHB1 | 1.58923340 |
| 28 | BLK | 1.57935952 |
| 29 | FRK | 1.57498192 |
| 30 | CDK12 | 1.56601307 |
| 31 | TBK1 | 1.56302261 |
| 32 | EIF2AK1 | 1.53134774 |
| 33 | MAP3K7 | 1.52348547 |
| 34 | TXK | 1.52131436 |
| 35 | MAP3K3 | 1.51698923 |
| 36 | TAOK2 | 1.48284691 |
| 37 | RIPK1 | 1.45779066 |
| 38 | DAPK2 | 1.44379283 |
| 39 | MAPK11 | 1.44183540 |
| 40 | JAK1 | 1.37282820 |
| 41 | JAK2 | 1.36968445 |
| 42 | ERBB2 | 1.28831296 |
| 43 | YES1 | 1.26830428 |
| 44 | FGR | 1.24318624 |
| 45 | MAP2K3 | 1.22099716 |
| 46 | PTK6 | 1.19112788 |
| 47 | HCK | 1.18750077 |
| 48 | CAMK1D | 1.18615110 |
| 49 | IKBKE | 1.18047179 |
| 50 | PRKAA2 | 1.17764643 |
| 51 | HIPK2 | 1.17695277 |
| 52 | SYK | 1.17213756 |
| 53 | EPHA4 | 1.16425364 |
| 54 | NLK | 1.12956649 |
| 55 | TNK2 | 1.07688015 |
| 56 | LMTK2 | 1.04879023 |
| 57 | ITK | 1.01767037 |
| 58 | BTK | 1.00661974 |
| 59 | MARK2 | 0.99078842 |
| 60 | FGFR2 | 0.97608018 |
| 61 | PIK3CG | 0.97550733 |
| 62 | FLT3 | 0.95907398 |
| 63 | CDK6 | 0.95682729 |
| 64 | PIM1 | 0.95626289 |
| 65 | PKN2 | 0.95329811 |
| 66 | ABL2 | 0.95240438 |
| 67 | MAP3K10 | 0.94605271 |
| 68 | STK38 | 0.94447439 |
| 69 | GRK6 | 0.89723366 |
| 70 | KSR2 | 0.89709692 |
| 71 | SGK494 | 0.87005561 |
| 72 | SGK223 | 0.87005561 |
| 73 | CAMK1G | 0.86282299 |
| 74 | LCK | 0.86121255 |
| 75 | NUAK1 | 0.84474031 |
| 76 | MAPK7 | 0.83359561 |
| 77 | MARK3 | 0.83205774 |
| 78 | EPHA3 | 0.81866654 |
| 79 | IRAK1 | 0.79693674 |
| 80 | PRKCZ | 0.79499881 |
| 81 | ACVR1B | 0.78054904 |
| 82 | MAP3K6 | 0.78053176 |
| 83 | STK4 | 0.76918573 |
| 84 | SIK2 | 0.75392977 |
| 85 | MAP3K11 | 0.74795577 |
| 86 | MAP2K1 | 0.73631791 |
| 87 | STK3 | 0.73519755 |
| 88 | NTRK3 | 0.72537437 |
| 89 | KSR1 | 0.72533926 |
| 90 | MAPK4 | 0.72428678 |
| 91 | ICK | 0.71786257 |
| 92 | MAPK12 | 0.71588831 |
| 93 | MAP3K5 | 0.71230992 |
| 94 | MAP2K2 | 0.70560018 |
| 95 | MAPK15 | 0.69211007 |
| 96 | PRKAA1 | 0.68875880 |
| 97 | CAMKK2 | 0.68316645 |
| 98 | TIE1 | 0.67049213 |
| 99 | TEC | 0.66638586 |
| 100 | FGFR3 | 0.65398355 |
| 101 | PINK1 | 0.65012732 |
| 102 | STK11 | 0.64238116 |
| 103 | MAP3K13 | 0.63863328 |
| 104 | PTK2B | 0.63838070 |
| 105 | DYRK1B | 0.63429628 |
| 106 | CSK | 0.63252121 |
| 107 | CHUK | 0.62999011 |
| 108 | MET | 0.62841871 |
| 109 | MELK | 0.62336598 |
| 110 | TAOK1 | 0.62203144 |
| 111 | TYRO3 | 0.61550823 |
| 112 | IRAK3 | 0.60939834 |
| 113 | TRIB3 | 0.59996757 |
| 114 | BMPR2 | 0.59625086 |
| 115 | STK38L | 0.58818424 |
| 116 | RET | 0.58642624 |
| 117 | SMG1 | 0.57919349 |
| 118 | PRKACG | 0.57515129 |
| 119 | CDK9 | 0.56958721 |
| 120 | CSF1R | 0.56764064 |
| 121 | MAP3K1 | 0.56356722 |
| 122 | KIT | 0.53905714 |
| 123 | IKBKB | 0.52096638 |
| 124 | CAMKK1 | 0.52074256 |
| 125 | CAMK4 | 0.52067658 |
| 126 | PRKD2 | 0.49945477 |
| 127 | PDGFRB | 0.49443452 |
| 128 | AKT3 | 0.48613517 |
| 129 | PRKCQ | 0.48553094 |
| 130 | PTK2 | 0.48540248 |
| 131 | MAP2K7 | 0.47928353 |
| 132 | RPS6KA2 | 0.47764794 |
| 133 | MAP2K6 | 0.46553986 |
| 134 | GSK3A | 0.45797927 |
| 135 | MAP3K4 | 0.44152408 |
| 136 | SGK1 | 0.43668109 |
| 137 | IGF1R | 0.43349036 |
| 138 | PDPK1 | 0.43052768 |
| 139 | GRK1 | 0.40788200 |
| 140 | SIK3 | 0.40158526 |
| 141 | LYN | 0.40144693 |
| 142 | EGFR | 0.39074445 |
| 143 | PDK1 | 0.37916330 |
| 144 | BMX | 0.36394214 |
| 145 | PAK3 | 0.36080388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.58486510 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.78145777 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.54384147 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26097465 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09386646 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.94665962 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70430979 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62937359 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44740643 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41931157 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.32118199 |
| 12 | AMPK signaling pathway_Homo sapiens_hsa04152 | 2.29384816 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.21265921 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.17489658 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.13667586 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.05882700 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.03107633 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02486756 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02469390 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02286285 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.01677746 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.99449009 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91235710 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89467946 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87467782 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.86186293 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.78607236 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70348329 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69200765 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.68062389 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63242247 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61842306 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60079985 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59356656 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56255572 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56017366 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.55707418 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53030606 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.51764732 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.49413039 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.47968245 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46774444 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44698647 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41986985 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37281859 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37063155 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35233129 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34703654 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.34043359 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.32147345 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31048148 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27307993 |
| 53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26887906 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21230779 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16380768 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 1.16271597 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 1.14930795 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 1.12847978 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12278451 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11585111 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10768096 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10062384 |
| 63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09997669 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09264411 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08773599 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02406184 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01485606 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 1.00942645 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98888974 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98027827 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96924810 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.95912734 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94524910 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93934691 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93028564 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92571358 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92397172 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91740264 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90880332 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88432635 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87742998 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87304926 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86887588 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.86787792 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84703208 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.84487418 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84336064 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83519467 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81223597 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81131273 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80139613 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75671564 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74037515 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.71235339 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71029565 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.70567564 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70439847 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70047089 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69417818 |
| 100 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69397567 |
| 101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69103431 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66154383 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.65373863 |
| 104 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64603822 |
| 105 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63307315 |
| 106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60059487 |
| 107 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56072080 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.55639312 |
| 109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55499756 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54816155 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50401601 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50235324 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50233038 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49989570 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49984633 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.49097730 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48743398 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47794333 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.47536572 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47300333 |
| 121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42681028 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41847010 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41767515 |
| 124 | Legionellosis_Homo sapiens_hsa05134 | 0.40465668 |
| 125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40144611 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.35568427 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.31458160 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28884948 |
| 129 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.28276168 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28112780 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.22281741 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19937201 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16753210 |
| 134 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14747421 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10969180 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08471107 |
| 137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.07470593 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06375140 |
| 139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06183406 |
| 140 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.05576478 |
| 141 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.02420410 |
| 142 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01410768 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | 0.00911038 |
| 144 | Bladder cancer_Homo sapiens_hsa05219 | -0.1607321 |
| 145 | Leishmaniasis_Homo sapiens_hsa05140 | -0.1587690 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1584697 |
| 147 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.1458434 |
| 148 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.1373952 |
| 149 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1147130 |
| 150 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | -0.1108356 |
| 151 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0831547 |
| 152 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0806495 |
| 153 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0768435 |
| 154 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0726499 |
| 155 | Pertussis_Homo sapiens_hsa05133 | -0.0635431 |
| 156 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0131335 |
| 157 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0130407 |
| 158 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0079414 |
| 159 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0036599 |

